The effect of myo-inositol supplementation on NAFLD
- Conditions
- on-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20210530051441N2
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 42
Age 18-55 years
Body mass index = 30-40 Kg /m2
Willingness to cooperate
Hepatic steatosis based on Grade 1 and 2 NAFLD disease
Athlete, pregnancy, lactation and menopause in women
Smoking and drinking alcohol
Adherence to a special diet or weight loss 3 months before the study
Use of chemical or herbal medicines for weight loss, hepatotoxic (phenytoin, amoxifine, lithium), lipid-lowering (statins), Insulin sensitizer, corticosteroids and non-steroidal, anti-inflammatory medications and any dietary supplements for 3 months before the study
History of weight loss surgery over the last year
those with cardiovascular, hepatic, renal, intestinal, thyroid and parathyroid dysfunction, billiary, any known autoimmune diseases, PCOs, cancers and conditions with mal-absorption such as Sprue and Crohn
Candidate or history of Liver transplant
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method